These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 5156644)

  • 1. Alkylating analogues of the tumour inhibitor 5-aziridino-2,4-dinitrobenzamide.
    Tisdale MJ
    Chem Biol Interact; 1971 Apr; 3(2):95-107. PubMed ID: 5156644
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumour-growth inhibitory nitrophenylaziridines and related compounds: structure-activity relationships.
    Khan AH; Ross WC
    Chem Biol Interact; 1969 Oct; 1(1):27-47. PubMed ID: 5407053
    [No Abstract]   [Full Text] [Related]  

  • 3. The sensitivity to chemotherapeutic agents of a rat tumour grown in immunosuppressed mice.
    Sheard CE; Double JA; Berenbaum MC
    Br J Cancer; 1971 Dec; 25(4):838-44. PubMed ID: 5144544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour-growth inhibitory nitrophenylaziridines and related compounds: structure-activity relationships. II.
    Khan AH; Ross WC
    Chem Biol Interact; 1971 Dec; 4(1):11-22. PubMed ID: 5156332
    [No Abstract]   [Full Text] [Related]  

  • 5. Potential anticancer agents. V. New aromatic nitrogen mustards related to 3-[N,N-bis(2-chloroethyl)amino]-4-methylbenzoic acid.
    Cambanis A; Dobre V; Niculescu-Duvăz I
    J Med Chem; 1969 Jan; 12(1):161-4. PubMed ID: 5763014
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis of new bis(1-aziridinyl) phosphinate alkylating agents containing O-phenyl N-phenylcarbamate side chains.
    Hsiao YY; Bardos TJ
    J Med Chem; 1973 Apr; 16(4):391-4. PubMed ID: 4716182
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the mechanism of action of 5-aziridinyl-2,4-dinitrobenzamide (CB 1954), a selective inhibitor of the Walker tumour.
    Connors TA; Melzack DH
    Int J Cancer; 1971 Jan; 7(1):86-92. PubMed ID: 5546147
    [No Abstract]   [Full Text] [Related]  

  • 8. Alkylating agents related to 2,2'-biaziridine. 3. The stereoisomeric N,N'-dimethanesulfonyl-2,2'-biaziridines.
    Feit PW; Nielsen OT
    J Med Chem; 1970 May; 13(3):447-52. PubMed ID: 5460301
    [No Abstract]   [Full Text] [Related]  

  • 9. Walker carcinosarcoma 256 in study of anticancer agents. II. Results.
    Everett J
    Cancer Res; 1966 Aug; 26(8 Pt 2):942-9. PubMed ID: 4224206
    [No Abstract]   [Full Text] [Related]  

  • 10. N-(2-chloroethyl)-N-(2-hydroxyethyl)arylamines. Possible intermediates to potential carcinolytic agents bearing dissimilar reactive functions.
    Foster AB; Jarman M; Ross WC; Tisdale MJ
    J Med Chem; 1972 Aug; 15(8):869-70. PubMed ID: 5044312
    [No Abstract]   [Full Text] [Related]  

  • 11. Structure-antitumor activity relationships among quinone derivatives.
    Driscoll JS; Hazard GF; Wood HB; Goldin A
    Cancer Chemother Rep 2; 1974 Apr; 4(2):1-362. PubMed ID: 4856629
    [No Abstract]   [Full Text] [Related]  

  • 12. Some antitumor agents derived from benzaldehyde nitrogen mustards.
    Florvall L
    Acta Pharm Suec; 1970 Apr; 7(2):87-104. PubMed ID: 5421623
    [No Abstract]   [Full Text] [Related]  

  • 13. Cell hybridization study of resistance to alkylating agents.
    Phillips BJ; Ambrose EJ
    Nat New Biol; 1971 Jun; 231(22):146-7. PubMed ID: 5283016
    [No Abstract]   [Full Text] [Related]  

  • 14. Anticancer activity of P,P-bis(2-methyl-1-aziridinyl)-N-2-pyrimidinylphosphinic amide (methylphosphazine) and related compounds.
    Noell CW; Cheng CC
    J Med Chem; 1968 Jan; 11(1):63-6. PubMed ID: 4966062
    [No Abstract]   [Full Text] [Related]  

  • 15. Growth inhibitory and haematological effects of alkylating agents and attempts at their modification to give greater selectivity of anti-tumour action.
    Elson LA
    Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):51-9. PubMed ID: 5659736
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the mechanism of action of 5-aziridinyl-2, 4-dinitrobenzamide in tumor cells.
    Mandel HG; Connors TA; Melzack DH; Merai K
    Cancer Res; 1974 Feb; 34(2):275-80. PubMed ID: 4855748
    [No Abstract]   [Full Text] [Related]  

  • 17. The clinical trial of an alkylating agent with a short half-life designed for intra-arterial chemotherapy.
    Meyza J; Cobb LM
    Cancer; 1971 Feb; 27(2):369-73. PubMed ID: 5100399
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the selectivity of antitumor agents.
    Garattini S; Guaitani A; Nanni E; Palma V
    Cancer Res; 1967 Dec; 27(12 Pt 2):1309-437. PubMed ID: 4295303
    [No Abstract]   [Full Text] [Related]  

  • 19. Alkylating agents related to 2,2'-biaziridine. II. N,N'-dicarbethoxy-2,2'-biaziridine.
    Feit PW; Nielsen OT
    J Med Chem; 1967 Sep; 10(5):927-32. PubMed ID: 6048504
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthfsis of bis(aziridinyl)phosphinyl-N-hydroxyurethane derivatives as antineoplastic agents.
    Hsiao YY; Bardos TJ; Wampler GL; Regelson W
    J Med Chem; 1975 Feb; 18(2):195-8. PubMed ID: 1120987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.